Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Bullboard Posts
Post by MBAon Feb 21, 2018 10:28am
330 Views
Post# 27593627

Institutions Must Be Getting Positions in VMD

Institutions Must Be Getting Positions in VMDIf the company is going to do about 0.65 per share in EBITDA with 40% organic growth in the health sector, and having a track record now of 7 good quarters demonstrating this success, I can see Institutional investors giving this company at least a 8x multiple at this time if not higher. 15 x will come as more quarters demonstrate the continued strong growth and good EBITDA numbers. May be explaining the strong buyer action yesterday and again today. Likely going to be strong momemtum for awhile until the SP gets to these multiples. Sellers today are idiots at under $3. A multiple of 8x is a $5.20 stock and 15x is $9.75. In addition the SP should also go higher each year with higher EBITDA numbers in 2019, 2020, etc. Don't see that kind of return with many stocks. Smiling even more this morning.
Bullboard Posts